how about abbvie allergan. what a merger. in late june i was in florence -- i was hiking the whole day this happened. abbvie offered 63 billion in cash and stock for allergan. that's the beleaguered maker of botox among many other drug, a 45% premium to where the stock had been trading but then again it's less than half of what pfizer offered for the same company a few years ago because it had execution issues. don't forget allergan back was a way to get a real tax break. now, management believes they can generate 2 billion and other cost reductions by year three and expect it to close in early 2020 it's pretty simple abbvie needs to diversify away from humira and need to do it fast allergan gives them exposure to medical aesthetics, eye care, women's health and by the way i think a very effective possible pill for migraine. when you get migraine and the growth rate has a boost too and believe to have the best prospects in the industry. i think that is hyperbole. abbvie expects the deal to boost earnings for share by 10% over

. >>> mv was up graded from to buy flo nurmt at usbitg om theism about kwipgs of allergan. shares up aut 2% today to 70.82. and activisionlizzard upgraded to buy from neutral. citing the gamingitles world of war craft classic ander m warfare. price target $64. shares rose 1% to 5 a.45. >> still ahead dhl goes high te for a speedy delivery. >>> dhl openshe u.s. innovation center as the global ship returns to robotics and other innovation to compete for e-commerce customers. i'm have that story coming up on "nightly businesreport." ♪ ♪ ♪ >>> income taxes are always a subject for heated discussio during presidential campaigns. as we mentioned earlierhey are expected to be fair game during the democratic candidate debate ght. but one income tax strategy that hasn't been mentioned so far during in campaign is the flat income tax where every income level pays the same rates. steve fbes who ran for president twice referred to it as the f frest incom tax. is it? we have two opposing views on that tonight. joining us leon la breck, the chief growth officer at is he f kwoiiaancial gr

. >> well the dose will be more consistent than the -- because any measure the major allergans. >> if approved 2-year-old natalie will only be able to use the off table type. the actual fda approved drug will be available for 4 to 17-year-olds but revocable trust still concerns. >> we don't know dsh if you stop it what would happen. >>? san francisco, luz pena, abc 7 news. >> san francisco is iconic cable cars out of commission nine more days, the final step in a three-year, $6 million restoration project of the gear boxes that propel the cable cars. some tourists visiting yesterday were disappointed >> just now we came here to get the cable car. and we couldn't get it. >> you know it's something we were looking forward. but it's okay. >> shuttle buss are running along the three routes during the shutdown. but there is plenty of other cool historic options for visitors and residents. muni has a fleet of historic stret cars. one believed to be used by harvey milk and open topped boat tram. you can check out historic cars at san francisco's railway museum. >>> 'tis the season to be scar

. >> well the dose will be more consistent than the -- because they measure the major allergans. >> ifroved 2-year-old natalie will only be able to use the off table type, the actual fda approved drug will be available for 4 to 17-year-olds but there are still concerns. >> we don't know if you stop it what would happen. >> in san francisco, luz pena, abc 7 news. >> san francisco's iconic cable cars are out of commission nine more days. it's the final step in a three-year, $$6 million restoration project of the gear boxes that propel the cars up the hills. the tourists visiting yesterday were disappointed >> no, we came here to get the cable car and couldn't get it. >> you know, it's something that we were looking forward. but it's okay. >> shuttle buses are running along the three routes during the shutdown. but there is also plenty of other cool historic options for visitors and residents alike. muni has a flet of historic street cars. including one believed to have been used by gay rights icon harvey milk and open topped boat tram. you can also check out historic cars at san francisc

. >> well the dose will be more consistent than the -- because they measure the major allergans. >> ifd, 2 can-year-old natalie willfda approved will b available for 4 to 17-year-olds but there are still concerns. >> we don't know if you stop it what would happen. >> in san francisco, luz pena, abc 7 news. >>> san francisco's iconic cable cars are out of commission for it's the final step in a three-year, $6 million restoration project of gear box nas propel the cars up the steep hills. some tourists visiting yesterday were disappointed >> just now we came here to get the cable car and we couldn't get it. >> you know it's something we were looking forward but it's okay. >> shuttle buses are running along the three routes during the shutdown. but there is also plenty of other cool historic options for visitors and residents alake. muni has ha fleet of historic street cars. one believed to have been used by gay rights icon harvey milk and open tropd boat tram. you can always check out historic cars as san francisco's railway museum. >>> and 'tis the season to be scared, right? it's now h

for example, last friday i told you to keep an eye on abbvie because of their process of acquiring allergan of up 3% thanks to the yougrade from citi and it was a good piece now another way that approach the group mulling over them and mulling over i dot to find a way to get people pharma exposure with less risk if the domestic drug stocks aren't working how about this, how about the foreign drug stocks as it turns out many are performing a lot better than its domestic peers the three that jump out o. astrazeneca, glass co-smithkline and novartis i think some of that might be because they have moderate u.s. exposure than their counterparts medicare for all or price controls would hurt them a little less. i'm not saying they have no exposure but i'm not saying they have more exposure it's just a little bert. when it comes to these three, they've each got something going for them right now that allows them to throw off the gravitational pull of the sector and allows them to rally let's start with astrazeneca i haven't thought about it for years because it was such a dog. this is a big british

that would be the acquisition of allergan and bristol-myers acquisition of celgene and their potential effects on prices. there is one additional matter i will be raising at this hearing. since the beginning of this administration, i have repeatedly had cause to raise concerns about reported white house attempts to interfere in antitrust enforcement efforts for political purposes. i've sent numerous letters to the department and the white house, concerning potential interference in antitrust law, based on statements that the president and administration officials reportedly made regarding matters such as the bayer monsanto merger, the at&t time warmer merger and the pending t-mobile sprint merger. not all of my letters were answered, but the responses i did get contained carefully worded assurances that the department followed procedures and it was, quote, not aware of any influence by the white house in any of the antitrust matters in question. the actual extent of any contact between white house officials and department enforcers concerning pending antitrust matters is still a myster

botox, that's allergan situation. >> yes >> we compete with invisalign. >> the new term, the slow feeion selfie did you see that part? >> honestly, i think there is so much we didn't really talk about that -- not just the -- what i think will be the good entertainment, but low level video, this kept multiple changes and how this -- the way it is able to do depth, night perception and fusion. i think we're all going to be as good as, say, i don't -- well, maybe like -- major directors. you know >> people will be able to produce some good content, apple streaming service. >> stop. >> i'm talking about citiz ingi cinematography, you know what happens next content. >> yes. >> looks good. >> good story, though. all the cinematography in the world is not going to help -- >> i'm your captain. >> i'm going to talk about philip morris and -- >> there i, killer content. >> that's a long-standing brand there, still going after all these years. sunshine let's talk about this deal, shall we it was, what, august 23th, so a few weeks ago, jim and i were on the set here, blind sided at the time by th